Published • loading... • Updated
Forge Bio Partners with Restore Vision to Advance AAV Therapies
Summary by BioProcess International
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Eli Lilly, Novo Nordisk, Crisp Therapeutics: Innovative drugs, artificial intelligence and corporate takeovers make the healthcare industry attractive again. Investors can benefit from these funds and ETFs.
·Düsseldorf, Germany
Read Full Article
Advanced therapies, such as CAR-Ts and gene therapies, have become one of the areas of greatest strategic interest for the pharmaceutical and biotechnology industry, both because of the volume of investment they mobilize and because of their potential to transform care models and generate new business development opportunities. The economic dimension of this sector is significant. By 2025, five cell and gene therapies reached the blockbuster cat…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
